SE7906119L - Lekemedel-retardform med olosliga porosa diffusionsholjen - Google Patents
Lekemedel-retardform med olosliga porosa diffusionsholjenInfo
- Publication number
- SE7906119L SE7906119L SE7906119A SE7906119A SE7906119L SE 7906119 L SE7906119 L SE 7906119L SE 7906119 A SE7906119 A SE 7906119A SE 7906119 A SE7906119 A SE 7906119A SE 7906119 L SE7906119 L SE 7906119L
- Authority
- SE
- Sweden
- Prior art keywords
- insulable
- porosa
- wrap
- toxic
- diffusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782831164 DE2831164A1 (de) | 1978-07-15 | 1978-07-15 | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
DE19782836387 DE2836387A1 (de) | 1978-08-19 | 1978-08-19 | Retardform fuer einen blutdrucksenkenden und antanginoes wirkenden stoff |
DE19782836388 DE2836388A1 (de) | 1978-08-19 | 1978-08-19 | Neue codein-retardform |
DE19782836357 DE2836357A1 (de) | 1978-08-19 | 1978-08-19 | Neue fenoterol-retardform |
DE19782836356 DE2836356A1 (de) | 1978-08-19 | 1978-08-19 | Neue clonidin-retardform |
DE19782836358 DE2836358A1 (de) | 1978-08-19 | 1978-08-19 | Neue etilefrin-retardform |
DE19782836419 DE2836419A1 (de) | 1978-08-19 | 1978-08-19 | Neue chinidin-retardform |
DE19782836447 DE2836447A1 (de) | 1978-08-19 | 1978-08-19 | Neue bunitrolol-retardform |
DE19782836355 DE2836355A1 (de) | 1978-08-19 | 1978-08-19 | Neue mexiletin-retardform |
DE2905602 | 1979-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7906119L true SE7906119L (sv) | 1980-01-16 |
Family
ID=27579139
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7906119A SE7906119L (sv) | 1978-07-15 | 1979-07-13 | Lekemedel-retardform med olosliga porosa diffusionsholjen |
Country Status (18)
Country | Link |
---|---|
US (3) | US4361546A (sv) |
AU (1) | AU4894779A (sv) |
BE (1) | BE877706A (sv) |
CA (1) | CA1126156A (sv) |
DD (1) | DD146547A5 (sv) |
DK (1) | DK296979A (sv) |
FI (1) | FI792204A (sv) |
FR (1) | FR2430766A1 (sv) |
GB (1) | GB2025227B (sv) |
GR (1) | GR71195B (sv) |
IL (1) | IL57796A0 (sv) |
IT (1) | IT1116877B (sv) |
LU (1) | LU81503A1 (sv) |
NL (1) | NL7905484A (sv) |
NO (1) | NO792335L (sv) |
PT (1) | PT69922A (sv) |
SE (1) | SE7906119L (sv) |
ZA (1) | ZA793542B (sv) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
FR2470599A1 (fr) * | 1979-12-07 | 1981-06-12 | Panoz Donald | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
FR2477015A1 (fr) * | 1980-03-03 | 1981-09-04 | Fabre Sa Pierre | Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire |
DE3124090A1 (de) | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
DE3126703A1 (de) | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
US4415547A (en) | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
US4704284A (en) * | 1982-08-12 | 1987-11-03 | Pfizer Inc. | Long-acting matrix tablet formulations |
DE3237575A1 (de) * | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
HU191542B (en) * | 1983-04-08 | 1987-03-30 | Boehringer Ingelheim Ltd | Process for production of pastiles containing dipyridamel independent from ph with regulated output of the active substance |
US4789516A (en) * | 1983-04-15 | 1988-12-06 | Damon Biotech, Inc | Production of sustained released system |
US4690682A (en) * | 1983-04-15 | 1987-09-01 | Damon Biotech, Inc. | Sustained release |
DE3314003A1 (de) * | 1983-04-18 | 1984-10-18 | Boehringer Ingelheim KG, 6507 Ingelheim | Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung |
GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
USRE33994E (en) * | 1983-08-16 | 1992-07-14 | Burroughs Wellcome Co. | Pharmaceutical delivery system |
JPS6051106A (ja) * | 1983-08-31 | 1985-03-22 | Yamanouchi Pharmaceut Co Ltd | 塩酸アモスラロ−ル持続性製剤 |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
US4917899A (en) * | 1983-12-22 | 1990-04-17 | Elan Corporation Plc | Controlled absorption diltiazem formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
IE59287B1 (en) * | 1984-02-10 | 1994-02-09 | Benzon Pharma As | Diffusion coated multiple-units dosage form |
GB8414221D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Unit dosage form |
GB8414220D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Medicaments in unit dose form |
EP0467488B1 (en) * | 1984-08-17 | 1995-10-11 | The Wellcome Foundation Limited | Composition for the controlled discharge of an active ingredient |
US5229132A (en) * | 1985-02-22 | 1993-07-20 | Grimberg Georges Serge | Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time |
US4666704A (en) * | 1985-05-24 | 1987-05-19 | International Minerals & Chemical Corp. | Controlled release delivery system for macromolecules |
CH666405A5 (de) * | 1985-06-24 | 1988-07-29 | Ciba Geigy Ag | Feste, haltbare darreichungsformen mit elastischem filmueberzug. |
EP0209071B2 (de) * | 1985-07-10 | 1998-07-15 | Novartis AG | Kontaktlinsenpflegesatz |
US4898733A (en) * | 1985-11-04 | 1990-02-06 | International Minerals & Chemical Corp. | Layered, compression molded device for the sustained release of a beneficial agent |
US4826688A (en) * | 1985-11-13 | 1989-05-02 | 501 Elan Corporation PLC. | Controlled absorption pharmaceutical formulation |
US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
US4717567A (en) * | 1985-11-25 | 1988-01-05 | Eastman Kodak Company | Rumen-stable pellets |
JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
DE3622487A1 (de) * | 1986-07-02 | 1988-01-14 | Schering Ag | Arzneimittel mit verzoegerter wirkstoffabgabe |
GB8616669D0 (en) * | 1986-07-09 | 1986-08-13 | Merk Sharpe & Dohme Ltd | Pharmaceutical compositions |
GB8618811D0 (en) * | 1986-08-01 | 1986-09-10 | Approved Prescription Services | Sustained release ibuprofen formulation |
DE3642648A1 (de) * | 1986-12-13 | 1988-06-23 | Boehringer Ingelheim Kg | Verwendung von 6-allyl-2-amino-5,6,7,8-tetrahydro-4h-thiazolo-(5,4-d)azepin zur freisetzung von wachstumshormon |
SE460945B (sv) * | 1987-01-15 | 1989-12-11 | Lejus Medical Ab | En multipel-unit-dos komposition av furosemid |
US5057317A (en) * | 1987-03-24 | 1991-10-15 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5499979A (en) * | 1987-06-25 | 1996-03-19 | Alza Corporation | Delivery system comprising kinetic forces |
US4957494A (en) * | 1987-06-25 | 1990-09-18 | Alza Corporation | Multi-layer delivery system |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US5219621A (en) * | 1987-10-16 | 1993-06-15 | Elan Corporation, Plc | Methods of treatment with diltiazem formulations |
US4851226A (en) * | 1987-11-16 | 1989-07-25 | Mcneil Consumer Products Company | Chewable medicament tablet containing means for taste masking |
US4804540A (en) * | 1987-12-16 | 1989-02-14 | G. D. Searle & Co. | Process for preparing the combination products of triamterene and hydrochlorothiazide |
FI101344B (sv) † | 1988-03-31 | 1998-06-15 | Tanabe Seiyaku Co | Förfarande för framställning av ett preparat för kontrollerat frigörin g av ett farmaceutiskt aktivt ämne |
GB8813032D0 (en) * | 1988-06-02 | 1988-07-06 | Boehringer Ingelheim Int | Antiviral pharmaceutical composition |
GB8913889D0 (en) * | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
NZ234227A (en) * | 1989-06-30 | 1991-08-27 | Smithkline Beecham Corp | Delayed release dosage form |
JPH03145418A (ja) * | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
CH678920A5 (sv) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
US5188836A (en) * | 1990-07-27 | 1993-02-23 | Warner-Lambert Company | Sustained release formulations |
US5760093A (en) * | 1991-02-27 | 1998-06-02 | Boehringer Ingelheim Kg | Halohydrocarbon-free delayed release lacquer solution for pharmaceutical preparation |
MX9200700A (es) * | 1991-02-27 | 1992-08-01 | Boehringer Ingelheim Kg | Solucion de laca retardante para preparaciones farmaceuticas. |
ATE120089T1 (de) * | 1991-05-20 | 1995-04-15 | Marion Laboratories Inc | Mehrschichtige zubereitung mit kontrollierter freisetzung. |
US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
US5436011A (en) * | 1993-04-16 | 1995-07-25 | Bristol-Myers Squibb Company | Solid pharmaceutical dosage form and a method for reducing abrasion |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6080428A (en) | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6129930A (en) * | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
US5484607A (en) * | 1993-10-13 | 1996-01-16 | Horacek; H. Joseph | Extended release clonidine formulation |
UA65607C2 (uk) | 1998-03-04 | 2004-04-15 | Орто-Макнейл Фармацевтикал, Інк. | Фармацевтична композиція (варіанти) та спосіб її приготування |
DE19820529A1 (de) | 1998-05-08 | 1999-11-11 | Lohmann Therapie Syst Lts | Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung |
US6669954B2 (en) | 2000-01-25 | 2003-12-30 | John R. Crison | Controlled release of drugs |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
ES2546258T3 (es) | 2005-03-22 | 2015-09-22 | Stada Arzneimittel Ag | Ibuprofeno solubilizado |
IL169678A (en) * | 2005-07-14 | 2010-11-30 | Innova Sa | Sweetener compositions |
NZ570039A (en) * | 2006-01-27 | 2011-07-29 | Eurand Inc | Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids |
CN101410093A (zh) * | 2006-01-27 | 2009-04-15 | 欧兰德股份有限公司 | 包含弱碱性药物和有机酸的药物递送系统 |
ATE390138T1 (de) * | 2006-02-09 | 2008-04-15 | Teva Pharma | Dipyridamol enthaltende zusammensetzungen mit verlängerter freisetzung und verfahren zu deren herstellung |
EP2155170A2 (en) * | 2007-06-08 | 2010-02-24 | Addrenex Pharmaceuticals, Inc. | Extended release formulation and method of treating adrenergic dysregulation |
US20100172991A1 (en) * | 2007-06-08 | 2010-07-08 | Henry Joseph Horacek | Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
BRPI0815387B8 (pt) * | 2007-08-13 | 2021-05-25 | Abuse Deterrent Pharmaceutical Llc | composição farmacêutica, método para fazer uma composição farmacêutica e uso da composição farmacêutica |
US20090196935A1 (en) * | 2008-02-01 | 2009-08-06 | Ahmed Salah U | Pharmaceutical Capsules Comprising Extended Release Dipyridamole Pellets |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
WO2010036975A2 (en) * | 2008-09-25 | 2010-04-01 | Teva Pharmaceutical Industries Ltd. | Dipyridamole and acetylsalicylic acid formulations and process for preparing same |
US20110003005A1 (en) * | 2009-07-06 | 2011-01-06 | Gopi Venkatesh | Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions |
IL208594A (en) | 2010-10-10 | 2014-11-30 | Innova Sa | The sweet preparations containing an octopus melting mixture from combination cellulose and sweetening sugar and methods for making them |
US8999393B1 (en) | 2013-01-09 | 2015-04-07 | Edgemont Pharmaceuticals Llc | Sustained release formulations of lorazepam |
US20140275038A1 (en) | 2013-03-15 | 2014-09-18 | Inspirion Delivery Technologies, Llc | Abuse deterrent compositions and methods of use |
US10231476B2 (en) | 2014-04-04 | 2019-03-19 | Douxmatok Ltd | Sweetener compositions and foods, beverages, and consumable products made thereof |
US20160242439A1 (en) | 2014-04-04 | 2016-08-25 | Douxmatok Ltd | Method for producing sweetener compositions and sweetener compositions |
US10207004B2 (en) | 2014-04-04 | 2019-02-19 | Douxmatok Ltd | Method for producing sweetener compositions and sweetener compositions |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
JP2024521460A (ja) | 2021-06-11 | 2024-05-31 | ルパン アトランティス ホールディングス エスエー | 経口投与用のメキシレチンの持続放出組成物 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2881085A (en) * | 1953-11-09 | 1959-04-07 | Abbott Lab | Thin film coating for tablets and the like |
US2853420A (en) * | 1956-01-25 | 1958-09-23 | Lowey Hans | Ethyl cellulose coatings for shaped medicinal preparations |
US2887440A (en) * | 1957-08-12 | 1959-05-19 | Dow Chemical Co | Enteric coating |
BE575775A (sv) * | 1958-02-18 | |||
US2971889A (en) * | 1958-03-18 | 1961-02-14 | Smith Kline French Lab | Press coated enteric tablets and process for preparing them |
US2928770A (en) * | 1958-11-28 | 1960-03-15 | Frank M Bardani | Sustained action pill |
US3096248A (en) * | 1959-04-06 | 1963-07-02 | Rexall Drug & Chemical Company | Method of making an encapsulated tablet |
DE1228757B (de) * | 1962-06-28 | 1966-11-17 | Haessle Ab | Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen |
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
FR1347413A (fr) * | 1963-01-29 | 1963-12-27 | Italnysco S P A | Sphérules ou globules à action étalée et procédé pour leur préparation |
NL297631A (sv) * | 1963-06-03 | |||
US3539380A (en) * | 1968-01-08 | 1970-11-10 | Upjohn Co | Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
JPS51123814A (en) | 1975-04-22 | 1976-10-28 | Shin Etsu Chem Co Ltd | A process for preparing gradually releasable solid medicines |
FR2353285A1 (fr) * | 1975-09-17 | 1977-12-30 | Doms Laboratoires | Medicament vasodilatateur coronarien perfectionne |
FR2377196A1 (fr) * | 1977-01-13 | 1978-08-11 | Lipha | Composition medicamenteuse a usage oral |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
-
1979
- 1979-07-12 DD DD79214300A patent/DD146547A5/de unknown
- 1979-07-13 GB GB7924504A patent/GB2025227B/en not_active Expired
- 1979-07-13 PT PT69922A patent/PT69922A/pt unknown
- 1979-07-13 FR FR7918301A patent/FR2430766A1/fr not_active Withdrawn
- 1979-07-13 IL IL57796A patent/IL57796A0/xx unknown
- 1979-07-13 DK DK296979A patent/DK296979A/da not_active Application Discontinuation
- 1979-07-13 NL NL7905484A patent/NL7905484A/nl not_active Application Discontinuation
- 1979-07-13 FI FI792204A patent/FI792204A/fi not_active Application Discontinuation
- 1979-07-13 GR GR59598A patent/GR71195B/el unknown
- 1979-07-13 NO NO792335A patent/NO792335L/no unknown
- 1979-07-13 IT IT49752/79A patent/IT1116877B/it active
- 1979-07-13 LU LU81503A patent/LU81503A1/de unknown
- 1979-07-13 ZA ZA00793542A patent/ZA793542B/xx unknown
- 1979-07-13 SE SE7906119A patent/SE7906119L/sv not_active Application Discontinuation
- 1979-07-13 BE BE0/196306A patent/BE877706A/fr unknown
- 1979-07-16 CA CA331,894A patent/CA1126156A/en not_active Expired
- 1979-07-16 AU AU48947/79A patent/AU4894779A/en not_active Abandoned
-
1981
- 1981-06-15 US US06/273,643 patent/US4361546A/en not_active Expired - Lifetime
-
1982
- 1982-08-18 US US06/409,131 patent/US4459279A/en not_active Expired - Lifetime
-
1984
- 1984-04-27 US US06/604,830 patent/US4578264A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI792204A (fi) | 1980-01-16 |
IL57796A0 (en) | 1979-11-30 |
NO792335L (no) | 1980-01-16 |
US4578264A (en) | 1986-03-25 |
LU81503A1 (de) | 1980-08-08 |
GB2025227B (en) | 1982-12-22 |
IT7949752A0 (it) | 1979-07-13 |
DD146547A5 (de) | 1981-02-18 |
DK296979A (da) | 1980-01-16 |
IT1116877B (it) | 1986-02-10 |
US4459279A (en) | 1984-07-10 |
GB2025227A (en) | 1980-01-23 |
PT69922A (de) | 1979-08-01 |
ZA793542B (en) | 1981-03-25 |
GR71195B (sv) | 1983-04-11 |
AU4894779A (en) | 1980-01-24 |
US4361546A (en) | 1982-11-30 |
BE877706A (fr) | 1980-01-14 |
NL7905484A (nl) | 1980-01-17 |
FR2430766A1 (fr) | 1980-02-08 |
CA1126156A (en) | 1982-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7906119L (sv) | Lekemedel-retardform med olosliga porosa diffusionsholjen | |
DE69229949D1 (de) | Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe | |
IT7923395A0 (it) | N-aril-ossazolidinoni, -ossazolidintioni, -pirrolidinoni, -pirrolidine e -tiazolidinoni, loro procedimento di preparazione eloro applicazione in terapia. | |
GR910100283A (el) | Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως. | |
IT8125722A0 (it) | Derivati amminoalchil-eterociclici, loro procedimento di preparazione eloro applicazione in terapia. | |
ES2001897A6 (es) | Procedimiento para la fabricacion de una tableta de liberacion controlada | |
DK344586D0 (da) | Tidskontrolleret laegemiddelafgivelse | |
IT8124835A0 (it) | Nuovi derivati di nor-tropano e granatano, loro procedimento di preparazione e loro applicazione in terapia. | |
DE3880593D1 (de) | Arzneizubereitungen mit retardierter wirkstofffreisetzung. | |
EP0013606A3 (en) | Polymeric diffusion matrix, method of its preparation and drug delivery device comprising said matrix | |
IL48962A0 (en) | Benzoylureido-diphenyl ethers,their preparation and their use as insecticides | |
NL191508C (nl) | Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. | |
CS188140B2 (en) | Herbicide agent and method of preparation of the active agent | |
NO148802C (no) | Fremgangsmaate og belegningspreparat for fremstilling av biologisk aktive preparater med regulert frigjoerelse av aktive bestanddeler | |
JPS5218813A (en) | Plasters for the relief of cutaneous diseases | |
ATE68686T1 (de) | System zum freigeben von stoffen in der vagina. | |
FR2466251B1 (fr) | Vaccin animal anticolibacillaire, obtention et application | |
IL57610A0 (en) | -amino-phenylacetic acid derivatives,their preparation and their use as herbicides and algicides | |
IT7820579A0 (it) | Derivati di n-fenil-1,3-ossazolidin-2,4-dionifungicidi e procedimento di preparazione. | |
YU47573B (sh) | Postupak za dobivanje čvrstog farmaceutskog preparata | |
IT8123488A0 (it) | Metaboliti, loro preparazione eloro impiego in terapeutica. | |
CS189021B2 (en) | Insecticide,acaricide means and method of preparation of active agents | |
DE2960968D1 (en) | Ethanolamine compounds, processes for their preparation, pharmaceutical preparations containing them and their medicinal use | |
DE3772954D1 (de) | Arzneimittel mit verzoegerter wirkstoffabgabe. | |
TR25921A (tr) | PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 7906119-8 |